<table>
<tr>
<th>Change</th>
<th>Details of Change</th>
<th>Level of Evidence</th>
</tr>
<tr>
<td>Rules for Classification - Pathological Classification</td>
<td>For assessment of pN, a selective neck dissection will ordinarily include 15 or more lymph nodes (previously 10 or more), and a comprehensive neck dissection (radical or modified radical neck dissection) will ordinarily include 22 or more lymph nodes (previously 15 or more).</td>
<td>IV</td>
</tr>
<tr>
<td>Definition of Primary Tumor (T)</td>
<td>Clinical and pathological depth of invasion (DOI) are now used in conjunction with size to determine the T category.</td>
<td>III</td>
</tr>
<tr>
<td>Definition of Primary Tumor (T)</td>
<td>Extrinsic tongue muscle invasion is no longer used in T4 because this is a feature of DOI.</td>
<td>III</td>
</tr>
<tr>
<td>Definition of Primary Tumor (T)</td>
<td>Distinction between lip and oral cavity has been removed from T4a, which is now defined as moderately advanced disease that invades adjacent structures only (e.g., through cortical bone of the mandible or maxilla, or involves the maxillary sinus or skin of the face).</td>
<td>IV</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Separate N staging approaches have been developed for HPV-related and HPV-unrelated cancers.</td>
<td>IT1,2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Separate N category approaches have been developed for patients treated without cervical lymph node dissection (clinical cN) and patients treated with cervical lymph neck dissection (pathological pN).</td>
<td>II1,2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Extranodal extension (ENE) is introduced as a descriptor in all HPV- unrelated cancers.</td>
<td>II2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>ENE in HPV negative cancers: Only clinically and radiographically overt ENE-ENE(+)-should be used for cN.</td>
<td>II2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>ENE in HPV negative cancers: Any pathologically detected ENE is considered ENE(+) and is used for pN.</td>
<td>II2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N) ☒</td>
<td>ENE in HPV-negative cancers: Presence of ENE is designated pN2a for a single ipsilateral node &lt;3 cm and pN3b for all other node(s).</td>
<td>II2</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Classification of ENE: Clinically overt ENE is classified as ENE, and is considered ENE(+) for cN.</td>
<td>III3</td>
</tr>
<tr>
<td>Definition of Regional Lymph Node (N)</td>
<td>Classification of ENE: Pathologically detected ENE is classified as either ENEmi (≤2mm) or ENEma (&gt;2mm) for data collection purposes only, but both are considered ENE(+) for definition of pN.</td>
<td>III3</td>
</tr>
<tr>
<td>Registry Data Collection Variables</td>
<td>Lip location has been removed.</td>
<td>IV</td>
</tr>
</table>  
##### ICD-O-3 Topography Codes  
<table>
<tr>
<th>Code</th>
<th>Description</th>
</tr>
<tr>
<td>C00.3</td>
<td>Mucosa of upper lip</td>
</tr>
<tr>
<td>C00.4</td>
<td>Mucosa of lower lip</td>
</tr>
<tr>
<td>C00.5</td>
<td>Mucosa of lip, NOS</td>
</tr>
<tr>
<td>C00.8</td>
<td>Overlapping lesion of lip</td>
</tr>
<tr>
<td>C00.9</td>
<td>Lip, NOS</td>
</tr>
<tr>
<td>C02.0</td>
<td>Dorsal surface of tongue, NOS</td>
</tr>
<tr>
<td>C02.1</td>
<td>Border of tongue</td>
</tr>
<tr>
<td>C02.2</td>
<td>Ventral surface of tongue, NOS</td>
</tr>
<tr>
<td>C02.3</td>
<td>Anterior two-thirds of tongue, NOS</td>
</tr>
<tr>
<td>C02.8</td>
<td>Overlapping lesion of tongue</td>
</tr>
<tr>
<td>C02.9</td>
<td>Tongue, NOS</td>
</tr>
<tr>
<td>C03.0</td>
<td>Upper gum</td>
</tr>
<tr>
<td>C03.1</td>
<td>Lower gum</td>
</tr>
<tr>
<td>C03.9</td>
<td>Gum, NOS</td>
</tr>
<tr>
<td>C04.0</td>
<td>Anterior floor of mouth</td>
</tr>
<tr>
<td>C04.1</td>
<td>Lateral floor of mouth</td>
</tr>
<tr>
<td>C04.8</td>
<td>Overlapping lesion of floor of mouth</td>
</tr>
<tr>
<td>C04.9</td>
<td>Floor of mouth, NOS</td>
</tr>
<tr>
<td>C05.0</td>
<td>Hard palate</td>
</tr>
<tr>
<td>C05.8</td>
<td>Overlapping lesion of palate</td>
</tr>
<tr>
<td>C05.9</td>
<td>Palate, NOS</td>
</tr>
<tr>
<td>C06.0</td>
<td>Cheek mucosa</td>
</tr>
<tr>
<td>C06.1</td>
<td>Vestibule of mouth</td>
</tr>
</table>
